background
object
chronic
obstruct
pulmonari
diseas
copd
chronic
progress
lung
diseas
hand
viral
infect
airway
associ
acut
exacerb
copd
systemat
review
metaanalysi
perform
determin
preval
rate
viral
infect
acut
exacerb
copd
patient
method
pubm
databas
systemat
search
populationbas
preval
studi
fix
random
effect
model
use
estim
summari
effects
betweenstudi
heterogen
public
bia
also
calcul
viral
infect
copd
patient
exacerb
two
critic
inclus
criteria
result
twentyeight
studi
select
articl
present
review
overal
estim
preval
viral
infect
ci
also
evid
heterogen
viral
infect
observ
among
studi
cochran
q
test
p
valu
isquar
highest
lowest
preval
rate
relat
rhinoviru
echoviru
respect
also
result
studi
show
preval
viral
infect
exacerb
copd
patient
fluctuat
year
slight
increas
decreas
conclus
result
systemat
review
demonstr
respiratori
viral
infect
import
role
acut
exacerb
copd
aecopd
addit
determin
exact
geograph
epidemiolog
virus
import
manag
treatment
infect
chronic
obstruct
pulmonari
diseas
copd
chronic
progress
lung
diseas
fourth
lead
caus
death
worldwid
million
peopl
worldwid
suffer
copd
cough
sputum
product
short
breath
common
symptom
copd
copd
exacerb
complic
statu
copd
diagnos
sudden
worsen
copd
symptom
includ
short
breath
quantiti
color
phlegm
mani
studi
impli
copd
acut
exacerb
multifactori
consequ
mainli
caus
respiratori
infect
smoke
air
pollut
genet
viral
infect
import
risk
factor
diseas
almost
peopl
experi
airway
viral
infect
life
case
improv
without
develop
chronic
respiratori
diseas
sever
studi
confirm
associ
airway
inflamm
tissu
remodel
destruct
airway
inflamm
central
role
pathogenesi
copd
hand
persist
infect
lead
chronic
inflamm
copd
patient
exacerb
mainli
due
frequent
infect
accord
role
virus
inflamm
involv
inflamm
copd
pathogenesi
studi
presenc
viral
infect
airway
highrisk
person
import
human
respiratori
virus
associ
exacerb
copd
divid
two
categori
major
virus
human
rhinoviru
influenza
viru
respiratori
syncyti
viru
rsv
minor
virus
parainfluenza
viru
coronaviru
human
metapneumoviru
adenoviru
import
prevent
problem
purpos
differ
techniqu
develop
includ
serolog
molecular
method
pcr
rtpcr
respiratori
virus
caus
aecopd
report
sever
studi
help
manag
aecopd
patient
aim
systemat
review
literatur
perform
metaanalysi
determin
frequenc
viral
infect
among
copd
patient
evalu
hypothesi
viral
infect
preval
rate
associ
copd
exacerb
systemat
search
conduct
use
pubm
identifi
avail
articl
march
accord
mesh
term
search
done
use
follow
keyword
chronic
obstruct
pulmonari
diseas
copd
exacerb
infect
microb
bacteria
viral
colon
alon
combin
togeth
boolean
oper
keywordstitl
abstract
field
also
refer
list
select
fulltext
paper
precis
search
manual
find
addit
citat
retriev
web
search
note
attempt
made
consid
unpublish
studi
furthermor
gray
literatur
dissert
relev
proceed
intern
congress
explor
final
restrict
search
origin
articl
abstract
publish
report
preval
viral
infect
copd
patient
literatur
search
conduct
two
independ
research
two
stage
disagr
among
research
resolv
discuss
necessari
third
research
journal
author
blind
studi
select
protocol
inclus
exclus
criteria
defin
elig
peerreview
public
accord
follow
criteria
pubm
articl
publish
articl
english
languag
report
preval
viral
infect
among
copd
patient
exacerb
studi
includ
sampl
sputum
nasopharyng
swab
nasal
lavag
report
data
relat
group
individu
taken
gener
popul
studi
use
pcr
realtim
pcr
rtpcr
cultur
method
major
exclus
criteria
list
follow
studi
unknown
sampl
origin
studi
fail
present
data
clearli
studi
conduct
anim
model
research
viral
h
jafarinejad
et
al
microbi
pathogenesi
bacteri
coinfect
studi
overlap
subject
time
place
sampl
collect
congress
abstract
review
articl
case
report
articl
studi
report
languag
english
metaanalysi
systemat
review
duplic
public
studi
prefer
report
item
systemat
review
metaanalysi
prisma
guidelin
use
assess
qualiti
includ
studi
prisma
statement
consist
checklist
fourphas
flow
diagram
complet
inform
list
extract
articl
microsoft
excel
worksheet
data
includ
first
author
name
public
date
sampl
size
preval
viral
infect
detect
method
research
locat
refer
extract
data
qualifi
two
research
independ
furthermor
unclear
data
consult
achiev
consensu
record
entri
dataset
cohen
kappa
agreement
coeffici
research
accept
equal
pool
rel
frequenc
rf
correspond
ci
use
evalu
preval
viral
infect
copd
diseas
invers
freemantukey
doubl
arcsin
transform
rel
frequenc
calcul
pool
rf
heterogen
variat
pool
estim
assess
use
cochran
q
test
respect
signific
consid
p
level
pool
rf
made
random
effect
model
heterogen
exist
individu
studi
otherwis
pool
effect
size
deriv
fix
effect
model
howev
sensit
analysi
done
success
remov
particular
studi
group
studi
highest
impact
heterogen
test
funnel
plot
establish
check
exist
public
bia
funnel
plot
asymmetri
measur
egger
linear
regress
test
begg
test
p
level
consid
statist
signific
public
bia
final
subgroup
analysi
use
detect
method
kind
sampl
geograph
contin
year
public
type
viru
statist
analys
conduct
use
data
analysi
statist
softwar
stata
version
stata
corpor
colleg
station
tx
total
articl
retriev
pubm
primari
screen
process
public
exclud
accord
copd
mesh
term
titl
abstract
copd
chronic
obstruct
pulmonari
diseas
retain
public
screen
accord
infect
mesh
term
includ
infect
microb
viru
viral
bacteri
probiot
influenza
colon
titl
abstract
result
public
public
manual
assess
viral
infect
titl
abstract
result
paper
elig
evalu
final
paper
retain
fulltext
evalu
studi
select
process
flowchart
literatur
search
shown
fig
tabl
characterist
studi
includ
systemat
review
metaanalysi
year
studi
eleven
studi
publish
other
later
lowest
studi
conduct
european
contin
england
america
contin
respect
addit
studi
conduct
asia
one
studi
use
nasal
lavag
oropharyng
swab
sampl
studi
use
nasopharyng
swab
sputum
sampl
respect
laboratori
techniqu
use
studi
pcr
realtim
pcr
rtpcr
cultur
use
studi
respect
inform
present
tabl
shown
pool
estim
preval
viral
infect
copd
patient
ci
among
patient
case
viral
infect
posit
also
heterogen
estim
pool
preval
among
studi
statist
signific
cochran
q
test
p
fig
tabl
accord
subgroup
analysi
highest
preval
viral
infect
copd
patient
relat
rhinoviru
first
subgroup
ci
studi
publish
second
subgroup
ci
studi
use
pcr
detect
third
subgroup
ci
studi
use
nasal
lavag
next
subgroup
ci
studi
conduct
europ
last
subgroup
ci
lowest
preval
viral
infect
relat
echoviru
ci
enteroviru
ci
respect
tabl
accord
lowess
smooth
analysi
preval
viral
infect
exacerb
copd
patient
fluctuat
year
nonsignific
slight
increas
decreas
fig
base
egger
regress
test
case
public
bia
statist
signific
addit
public
bia
detect
accord
begg
adjust
rank
correl
test
tabl
fig
sensit
analysi
perform
sequenti
omiss
individu
studi
pool
preval
sequenti
omiss
significantli
chang
ci
indic
result
statist
robust
fig
metaanalysi
perform
estim
geograph
distribut
viral
infect
copd
patient
worldwid
accord
sensit
analysi
result
metaanalysi
robust
includ
studi
funnel
plot
indic
nonsignific
right
bia
assum
gener
symmetri
assumpt
previou
studi
demonstr
exacerb
copd
virus
frequent
detect
immun
system
respons
virus
may
involv
sever
exacerb
exampl
increas
level
due
rhinoviru
infect
anoth
effect
factor
increas
oxid
stress
respons
viral
infect
copd
exacerb
exacerb
level
plasma
fibrinogen
increas
significantli
suggest
respiratori
viral
infect
increas
system
inflamm
thu
increas
frequenc
aecopd
recent
studi
pcr
base
method
use
extens
detect
result
increas
sensit
viral
detect
time
method
addit
metaanalysi
studi
pcr
base
method
common
detect
method
confirm
mani
studi
respiratori
virus
involv
aecopd
patient
sensit
molecular
method
role
virus
copd
pathogenesi
better
understand
seemung
addit
demonstr
copd
patient
viral
infect
higher
inflammatori
cytokin
level
compar
copd
patient
neg
viral
infect
healthi
control
show
direct
associ
viral
infect
copd
exacerb
among
virus
found
copd
patient
rhinoviru
common
viru
mayb
due
fact
viru
major
caus
common
cold
also
widespread
commun
rohd
et
al
germani
perform
casecontrol
studi
aecopd
patient
detect
viral
infect
aecopd
group
compar
control
suggest
possibl
associ
respiratori
viral
infect
copd
exacerb
also
demonstr
higher
rate
viral
detect
sputum
sampl
nasal
lavag
anoth
studi
hutchinson
et
al
australia
demonstr
virus
parainfluenza
influenza
picornaviru
strongli
associ
develop
aecopd
previou
studi
show
picornaviru
common
viru
associ
aecopd
follow
influenza
rsv
studi
overal
preval
viral
infect
copd
patient
detect
virus
rhinoviru
influenza
rsv
last
one
echoviru
enteroviru
wu
polyoma
viru
differ
preval
viral
infect
patient
could
mani
reason
geograph
region
sampl
type
sampl
size
sampl
time
sampl
transport
system
type
techniqu
current
studi
demonstr
preval
viral
infect
copd
patient
slightli
increas
year
public
decreas
possibl
reason
may
increas
individu
social
health
level
vaccin
virus
prophylaxi
patient
etc
develop
laboratori
molecular
detect
method
role
viral
infect
copd
patient
underestim
develop
sensit
specif
molecular
method
becam
clear
first
line
defens
aecopd
patient
treat
antibiot
base
two
factor
includ
sever
copd
sever
exacerb
obviou
overus
unnecessari
antibiot
therapi
treatment
viral
infect
may
simultan
lead
advent
multidrug
resist
bacteria
real
causal
agent
current
infect
therefor
appli
sensit
rapid
method
definit
diagnosi
real
caus
diseas
help
make
precis
exact
treatment
aecopd
patient
viral
infect
avoid
unnecessari
use
antibiot
hand
rapid
method
reduc
patient
cost
prevent
antibiot
resist
bacteria
addit
accord
associ
copd
exacerb
respiratori
viral
infect
effect
control
prevent
therapi
viral
infect
need
